DURATA THERAPEUTICS INC's ticker is DRTX and the CUSIP is 26658A107. A total of 75 filers reported holding DURATA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 1.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $309,000 | – | 18,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 508,472 | $4,596,000 | 3.19% |
| Broadfin Capital, LLC | 383,227 | $3,464,000 | 0.62% |
| Orbimed Advisors | 1,785,714 | $16,143,000 | 0.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,979 | $2,495,000 | 0.12% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,188,571 | $10,745,000 | 0.10% |
| Lenox Wealth Advisors, LLC | 8,000 | $72,000 | 0.07% |
| STONERIDGE INVESTMENT PARTNERS LLC | 30,732 | $278,000 | 0.06% |
| Loeb Offshore Management LP | 19,621 | $177,000 | 0.06% |
| Alyeska Investment Group, L.P. | 100,000 | $904,000 | 0.04% |
| PARADIGM ASSET MANAGEMENT CO LLC | 25,000 | $226,000,000 | 0.04% |